CIK: 0001325083 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 15, 2023
Total Value ($000): $82,490 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 3,015,668 | $25,301 | 30.7% | $7.17 | +37.5% | COM | 01438T106 |
| — | Biohaven Pharmactl Hldg Co L | 450,422 | $10,774 | 13.1% | $32.04 | — | COM | G11196105 |
| — | Avadel Pharmaceuticals Plc | 500,000 | $8,240 | 10.0% | $16.48 | — | SPONSORED ADR | 05337M104 |
| — | HOOKIPA PHARMA | 5,517,385 | $4,855 | 5.9% | $0.87 | — | COM | 43906K100 |
| — | Applied Therapeutics Inc | 3,450,000 | $4,416 | 5.4% | $5.66 | — | COM | 03828A101 |
| — | Verona Pharma | 200,000 | $4,228 | 5.1% | $22.97 | — | SPONSORED ADS | 925050106 |
| GDX | Vaneck Gold Miners ETF | 91,850 | $2,766 | 3.4% | $28.66 | — | Gold Miners ETF | 92189F106 |
| SIL | Global X Silver Miners ETF 37954Y848 | 89,700 | $2,331 | 2.8% | $28.17 | — | Global X Silver | 37954Y848 |
| ENTX | Entera Bio Ltd | 2,484,275 | $2,094 | 2.5% | $3.46 | -75.3% | SHS | M40527109 |
| GDXJ | Vaneck Junior Gold Miners ETF | 53,150 | $1,895 | 2.3% | $35.65 | — | Junior Hold Mine | 92189F791 |
| BAH | Booz Allen Hamilton HLDG COR | 13,000 | $1,451 | 1.8% | $76.36 | +22.6% | CL A | 099502106 |
| V | Visa | 4,850 | $1,152 | 1.4% | $203.18 | +10.5% | COM CL A | 92826C839 |
| TMO | Thermo Fischer Scientific Inc | 2,100 | $1,096 | 1.3% | $471.13 | +13.6% | COM | 883556102 |
| OCUL | Ocular Therapeutix Inc. | 200,000 | $1,032 | 1.3% | $4.75 | +25.2% | COM | 67576A100 |
| MO | Altria Group Inc | 22,700 | $1,028 | 1.2% | $30.41 | +20.2% | COM | 02209S103 |
| CVS | CVS Health Corp | 14,500 | $1,002 | 1.2% | $62.28 | +3.2% | COM | 126650100 |
| FNV | Franco Nev Corp CAD | 7,000 | $998 | 1.2% | $135.73 | +7.9% | COM | 351858105 |
| — | Silvercrest Metals Inc CAD | 170,000 | $996 | 1.2% | $6.14 | — | COM | 828363101 |
| NOC | Northrop Grumman Corp | 2,165 | $987 | 1.2% | $442.02 | -1.9% | COM | 666807102 |
| — | OSISKO GOLD ROYALTIES LTD | 400,000 | $969 | 1.2% | $2.88 | — | COM | 68827L101 |
| — | Omega Therapeutics Inc. | 173,010 | $969 | 1.2% | $6.03 | — | COM | 68217N105 |
| SA | SEABRIDGE GOLD INC | 80,000 | $964 | 1.2% | $14.95 | -9.1% | COM | 811916105 |
| — | Orgenesis, Inc. | 634,738 | $882 | 1.1% | $6.08 | — | COM | 68619K105 |
| OCUL | Ocular Therapeutix Inc. | 95,800 | $814 | 1.0% | $4.75 | +25.2% | Call | 67576A100 |
| ALT | Altimmune Inc | 173,864 | $614 | 0.7% | $12.66 | -64.5% | COM NEW | 02155H200 |
| IRD | Ocuphire Pharma Inc. | 100,000 | $434 | 0.5% | $3.59 | +32.2% | COM | 67577R102 |
| — | BioXcell | 30,000 | $200 | 0.2% | $6.66 | — | COM | 09075P105 |